Cymbalta is the brand name for duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI). It's FDA-approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. The dual antidepressant and analgesic profile makes it particularly useful when anxiety coexists with chronic pain. Typical effective dose for anxiety is 60 to 120 mg per day.
What Cymbalta is
Cymbalta is the brand name for duloxetine, a medication in the SNRI class. It was approved by the FDA in 2004 for major depression and diabetic neuropathy. The generalized anxiety disorder indication followed in 2007. Generic duloxetine is widely available and clinically equivalent. The MedlinePlus drug information page for duloxetine covers the patient-facing essentials.
The SNRI class reference is SNRIs explained, which sets duloxetine in context with venlafaxine and the rest of the class.
What it does
Duloxetine blocks reuptake of serotonin and norepinephrine across the dose range, with both effects relatively balanced. Over weeks, this produces the same adaptation in anxiety circuitry that other serotonergic antidepressants produce. The norepinephrine component also has descending-pathway effects in the spinal cord that reduce the perception of chronic pain, which is the mechanism behind the pain indications. To see the mechanism animated, try PsychiatryRx's guide to how serotonin and norepinephrine reuptake inhibitors work.
The anxiety effect develops over four to six weeks. Pain reductions, when present, often appear earlier.
What it feels like
Patients describe the same general arc as on other antidepressants: worry softens, sleep often consolidates, physical tension comes down. Patients with co-occurring chronic pain often notice the pain effect before the anxiety effect.
Early side effects in the first weeks include nausea (often more prominent than with SSRIs), dry mouth, constipation, headache, dizziness, fatigue or sedation in some patients, and sweating. Nausea usually settles within two weeks and is reduced by taking with food. Sexual side effects are common.
When it's chosen
Cymbalta is often chosen for:
- Generalized anxiety disorder, particularly when an SSRI hasn't produced enough response
- Patients with co-occurring chronic pain: fibromyalgia, diabetic neuropathy, chronic low back pain, osteoarthritis pain
- Patients with co-occurring anxiety and depression, where the antidepressant effect on both is useful
- Older adults with chronic pain and anxiety, when the alternative would be NSAIDs or opioids
It's less often chosen first-line for panic disorder, OCD, or PTSD; SSRIs have stronger evidence in those conditions.
Typical dosing and timeline
Starting dose is 30 mg daily for one week, then 60 mg, taken once daily with or without food. Most patients respond to 60 mg. Some require 90 to 120 mg for full effect. The FDA-approved maximum for anxiety is 120 mg daily. Above 60 mg, the incremental benefit is modest and the side effect burden rises.
The therapeutic effect on anxiety develops over four to six weeks at a stable dose.
Side effects and cautions
Nausea, dry mouth, constipation, sweating, and sexual dysfunction are the most distinctive side effects. Liver function should be considered before starting; duloxetine isn't recommended in patients with significant liver disease or in patients with substantial daily alcohol intake. Modest blood pressure changes are possible but smaller than with venlafaxine at high doses.
The NIMH overview of mental health medications describes the SNRI class. The FDA boxed warning on increased suicidal thoughts in patients under 25 in the first months applies to SNRIs as well as SSRIs.
Discontinuation syndrome is the most distinctive concern: dizziness, electric-shock sensations, flu-like symptoms, and irritability with abrupt stopping. A slow taper over weeks is the standard approach.
What Cymbalta doesn't do
Cymbalta doesn't produce an immediate calming effect. The therapeutic action is from weeks of receptor adaptation.
Cymbalta isn't a controlled substance and doesn't produce addiction. It does produce physical adaptation, which is why a taper is required.
Cymbalta isn't a substitute for therapy. As with other antidepressants for anxiety, combined treatment with CBT tends to produce more durable outcomes than medication alone, particularly for panic disorder and OCD.
Comparison with related medications
Compared with venlafaxine, duloxetine has stronger pain indications and less dose-related blood pressure effect; venlafaxine has more dosing flexibility at lower doses. See the Effexor vs Cymbalta comparison. Compared with Lexapro or sertraline, duloxetine adds a norepinephrine and analgesic component but has a more pronounced discontinuation syndrome.